The Science Behind Our Formulas | Clinical Research + Study Links
RU-58841 is a non-steroidal anti-androgen that binds to androgen receptors at the hair follicle, blocking DHT locally without systemic hormonal disruption. Combined with minoxidil (the only FDA-approved topical for hair regrowth) and carrier oils that nourish the scalp.
DHT Blocking
RU-58841 targets androgen receptors at the follicle only. No systemic DHT suppression. No sexual side effects reported in topical use.
Approved Base
Minoxidil is the only FDA-approved topical treatment for androgenetic alopecia. Proven to stimulate the growth phase of the hair cycle.
100% drug-free. Every ingredient is a plant-derived oil or botanical extract with published research supporting hair growth, scalp health, or DHT inhibition through natural pathways.
Hair Count Increase
Men taking pumpkin seed oil for 24 weeks saw 40% more hair vs 10% in the placebo group. Randomized, double-blind, placebo-controlled.
Matched Minoxidil
Rosemary oil performed equally to 2% minoxidil for androgenetic alopecia over 6 months. Same regrowth. Zero drugs.
Reduced Hair Loss
Castor oil's ricinoleic acid inhibits prostaglandin D2, linked to follicle miniaturization. Topical studies show reduced shedding.
Formulated to strengthen existing hair, add real volume, and support a healthy scalp environment between serum applications. No silicones. No sulfates. Every ingredient has a job.
Biotin (Vitamin B7)
Supports keratin infrastructure. Deficiency directly linked to hair loss. Topical delivery strengthens the shaft and reduces breakage.
Caffeine Growth Boost
Topical caffeine increased hair follicle growth by 46% and extended the growth phase by 37% in ex-vivo human studies.
Active Botanicals
Maca root, rice protein, horsetail, shea butter, aloe, slippery elm, coconut oil, castor oil, peppermint. Every ingredient pulls its weight.
Third-Party Purity & Heavy Metal Testing
We complete independent lab testing on all Reclaim Gang products for purity verification and heavy metal screening quarterly. Results will be published here with full certificates of analysis.
Expected availability: Early Q2 2026
Ready to Start?
Pick your product. Read the research. Make your own call.